RxAnte

RxAnte is a leading predictive analytics and clinical services company founded in 2011. The company's slogan "Get more from medicines with patented analytics and value-based pharmacy services" reflects its core mission. RxAnte is dedicated to improving medication use and health outcomes by providing health plans and providers with actionable insights, strategies, and a portfolio of interventions. With a focus on Analytics, Health Care, and Pharmaceutical industries, RxAnte offers a range of solutions including patented platforms leveraging predictive and decision analytics, advanced program evaluation methods, a web-based workflow solution, and an award-winning call center. Its expertise in advanced analytics, medication adherence, health IT, and quality improvement sets it apart in the market. In December 20, 2022, RxAnte received a $15.00M Venture Round investment from Trinity Capital, highlighting investor confidence in the company's innovative approach and potential for growth. RxAnte's commitment to making medications work better for everyone positions it as a promising investment opportunity in the evolving healthcare landscape.